1:52 PM
 | 
Apr 03, 2019
 |  BC Extra  |  Financial News

Rare muscle disease start-up Dyne raises $50M series A

Founded and incubated by Atlas Venture, newly launched Dyne Therapeutics Inc. (Cambridge, Mass.) announced a $50 million series A round with which it intends to develop therapies that deliver oligonucleotides directly into muscle to treat rare diseases.

Forbion and MPM...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >